Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 2,000 shares of its Series A ... read more

Covington & Burling is adding a highly regarded corporate team to its Beijing and Silicon Valley offices, bolstering Covington’s global transactional capabilities in the technology and life sciences sectors. The firm is pleased to announce that Michelle Edwards, Eva Wang and ... read more

Date: ... read more

Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that Jack Talley, President and Chief Executive Officer, will be presenting at the 14th Annual BIO CEO & Investor Conference on Monday, February 13, 2012 at ... read more

Anacor Pharmaceuticals (Nasdaq:ANAC), today announced the sale of 3.25 million shares of its common stock for gross proceeds of $21,450,000 pursuant to an underwriting agreement with Canaccord Genuity acting as the sole bookrunner. In addition, the Company has granted the underwriters a 30-day option to purchase ... read more

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the fourth quarter and fiscal year ended December 31, 2011. Total revenue for the fourth quarter was $65.1 million, as compared to total revenue of $84.9 million for the same period of 2010. For the full year ... read more

Fluidigm Corporation (NASDAQ:FLDM) today announced that it will report its fourth quarter and 2011 full year financial results on February 14, 2012, after close of market. Fluidigm President and Chief Executive Officer Gajus Worthington, and Chief Financial Officer Vikram ... read more

TargetCancer, a non-profit organization dedicated to promoting the development of lifesaving treatment protocols for rare cancers, is proud to announce over $70,000 in new grants to fund rare cancer research. “We are enormously proud to announce these new grants today. Only two ... read more

By harnessing quantum dots—tiny light-emitting semiconductor particles a few billionths of a meter across—researchers at the University of Washington (UW) have developed a new and vastly more targeted way to stimulate neurons in the brain. Being able to switch neurons on and off and monitor how ... read more

Space Exploration Technologies (SpaceX), the world’s fastest growing space launch company, and Asia Satellite Telecommunications Company Limited (AsiaSat), the leading regional satellite operator in Asia, today announced an agreement to launch two AsiaSat communications satellites using SpaceX’s Falcon 9 rocket in 2014. ... read more

Vince & Associates Clinical Research, the premier provider of innovative early clinical research services to the global biopharmaceutical industry, announces the certification of their pharmacy clean room in compliance with United States Pharmacopeia USP <797> guidelines. This certification enables Vince & Associates Clinical Research to prepare ... read more

Inviragen, Inc. and Advanced BioScience Laboratories Inc. (ABL), a biomedical contract research and manufacturing organization, today announced the signing of a contract manufacturing agreement between the two companies. Under this agreement, ABL will be responsible for the production and characterization of a master virus seed stock, ... read more

Relypsa, Inc. today announced the hiring of Lance Berman, M.D. as its Senior Vice President of Commercial Strategy & Medical Affairs. Dr. Berman will oversee all pre-launch planning and activities supporting the company’s commercialization strategy for RLY5016, a first-in-class compound in late-stage development for the chronic ... read more

Clinipace Worldwide, a global digital contract research organization (dCRO) that has pioneered technology-amplified contract research services, announced today the appointment of Jürgen Frisch, MD, to Chief Medical Officer of European Operations. In this ... read more

MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences. The 14th Annual BioCEO Investor Conference on February 14, ... read more

Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today announced that its Board of Directors thoroughly reviewed Roche’s unsolicited tender offer with the assistance of its financial and legal advisors ... read more

TruTouch Technologies, a pioneer in non-invasive biometric intoxication detection systems, today announced that it has secured $3M which will enable the company to build sales revenues through direct sales and secure additional licensing partners. Dr. Richard D. Gill, President ... read more

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application for pertuzumab and granted Priority Review. The proposed indication is pertuzumab in combination with Herceptin® (trastuzumab) and ... read more

Aviir, a biotechnology company specializing in cardiac risk assessment and Guard A Heart, a non-profit foundation dedicated to raising awareness about heart disease, announced they will be presenting the first Guardian of Hearts Award to Larry King in recognition of his ... read more

CENIC, the Pacific Northwest Gigapop, (PNWGP), and Internet2 today announced plans for a major, long-term collaboration to deploy 100 Gigabit per second (Gbps) networking capabilities across the entire West Coast of the United States, to share a common optical networking infrastructure, and to work on many ... read more